We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
(MM) | NASDAQ:CNSI | NASDAQ | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.49 | 0.00 | 00:00:00 |
Xura, Inc. ("Xura") (NASDAQ:MESG), formerly known as Comverse, Inc. (NASDAQ:CNSI), today announced its results for the second fiscal quarter ended July 31, 2015.
Consolidated Highlights: Below is selected consolidated financial information for the three and six months ended July 31, 2015 and 2014, prepared in accordance with generally accepted accounting principles ("GAAP"), except as noted.
Xura, Inc.: | Three Months Ended July 31, | Six Months Ended July 31, | ||
(In thousands) | 2015 | 2014 | 2015 | 2014 |
Total revenue | $ 61,629 | $ 74,988 | $ 107,334 | $ 140,070 |
Costs and expenses | ||||
Cost of revenue | 39,964 | 57,956 | 83,721 | 108,841 |
Research and development, net | 8,235 | 9,813 | 16,515 | 18,172 |
Selling, general and administrative | 19,686 | 23,059 | 39,559 | 48,619 |
Other operating expenses | 4,238 | 1,171 | 7,646 | 3,043 |
Total costs and expenses | 72,123 | 91,999 | 147,441 | 178,675 |
Loss from operations | (10,494) | (17,011) | (40,107) | (38,605) |
Expense adjustments | 9,878 | 5,489 | 17,642 | 11,366 |
Xura performance (1) | (616) | (11,522) | (22,465) | (27,239) |
Depreciation | 3,339 | 3,261 | 6,706 | 6,422 |
Adjusted EBITDA (1) | 2,723 | (8,261) | (15,759) | (20,817) |
Loss before income tax benefit (expense) | (14,697) | (20,504) | (49,890) | (40,139) |
Income tax benefit (expense) | 2,534 | (1,877) | (2,253) | (4,337) |
Loss from continuing operations | (12,163) | (22,381) | (52,143) | (44,476) |
Income from discontinued operations | 175,060 | 5,515 | 188,379 | 11,479 |
Net income (loss) | $ 162,897 | $ (16,866) | $ 136,236 | $ (32,997) |
Earnings (loss) per share - basic & diluted: | ||||
Continuing operations | $ (0.55) | $ (1.00) | $ (2.38) | $ (1.99) |
Discontinued operations | 7.95 | 0.25 | 8.59 | 0.51 |
$ 7.40 | $ (0.75) | $ 6.21 | $ (1.48) | |
Adjusted EBITDA earnings (loss) per share - basic & diluted (1) | $ 0.12 | $ (0.37) | $ (0.72) | $ (0.93) |
Interest expense | (167) | (231) | (360) | (354) |
Operating margin | (17.0)% | (22.7)% | (37.4)% | (27.6)% |
Xura performance margin | (1.0)% | (15.4)% | (20.9)% | (19.4)% |
Adjusted EBITDA margin | 4.4 % | (11.0)% | (14.7)% | (14.9)% |
Net cash used in operating activities | $ (31,559) | $ (13,785) | $ (49,263) | $ (49,384) |
(1) "Xura performance", "Adjusted EBITDA" and "Adjusted EBITDA earnings (loss) per share" have not been prepared in accordance with GAAP. See "Presentation of Non-GAAP Financial Measures" below. |
"We are proud to be in a position today to unveil our new company name and brand identity, Xura, along with our new stock symbol, MESG, which effectively redefines our role in enabling digital communications for both consumers and enterprise customers. We are pushing forward aggressively to stake our leadership in the rapidly evolving digital communications space. All the actions we have taken in 2015, including our partnership with Tech Mahindra, completion of the sale of the BSS segment to Amdocs and our acquisition of Acision, have helped position us to achieve the high operational and financial goals we have established for our new, combined company, Xura. We are very excited about leveraging our merged opportunities into strong results and begin truly disrupting digital," said Philippe Tartavull, President and Chief Executive Officer, Xura, Inc.
Discontinued Operations and Segment Information
Pursuant to the Amdocs Purchase Agreement, we agreed to sell substantially all of our assets required for operating the BSS Business. We substantially completed the disposition and have re-classified and reflected its operations as discontinued operations on the consolidated statements of earnings for all periods presented. As of July 31, 2015, certain assets and liabilities continued to meet the held for sale criteria due to deferred closings.
Selected Balance Sheet Highlights: Below is selected balance sheet data:
As of | ||
(In millions) | July 31, 2015 | April 30, 2015 |
Cash and cash equivalents | $ 346.1 | $ 136.1 |
Restricted cash (including long-term restricted cash) and bank time deposits | 60.8 | 43.8 |
Total | $ 406.9 | $ 179.9 |
As previously disclosed, on August 6, 2015, the company paid approximately $136 million in cash as part of the consideration for the acquisition of Acision.
Conference Call Details
Xura will be conducting a conference call today, September 9, 2015 at 8:00 a.m. ET. To listen to the conference call live, please dial (678) 825-8369. Please dial-in at least ten minutes before the scheduled start time. A live webcast and presentation can be accessed at www.Xura.com by following links to the events and presentations page under the Investors section. Following the call, a replay of the webcast will be archived in the same location.
Xura Performance and Adjusted EBITDA
Our Chief Executive Officer is our chief operating decision maker (or CODM). The CODM uses Xura performance, as defined below, as the primary basis for assessing the financial results of the company. Xura performance, as we define it in accordance with the Financial Accounting Standards Board's guidance relating to segment reporting, is not necessarily comparable to other similarly titled captions of other companies.
Xura performance is computed by management as loss from operations adjusted for the following: (i) stock-based compensation expense; (ii) amortization of intangible assets; (iii) compliance-related professional fees; (iv) compliance-related compensation and other expenses; (v) strategic-related costs (vi) write-off of property and equipment; (vii) certain litigation settlements and related costs; (viii) restructuring expenses; and (ix) certain other gains, losses and expenses. Strategic related costs include business strategy evaluation and mergers and acquisition efforts.
Adjusted EBITDA is computed by management by adding depreciation to Xura performance.
Presentation of Non-GAAP Financial Measures
We provide Xura performance, Adjusted EBITDA and Adjusted EBITDA per share, non-GAAP financial measures, as additional information for our operating results. These measures are not in accordance with, or alternatives for, GAAP financial measures and may be different from, or not comparable to similarly titled or other non-GAAP financial measures used by other companies. We believe that the presentation of these non-GAAP financial measures provide useful information to investors regarding certain additional financial and business trends relating to our results of operations as viewed by management in monitoring our businesses, reviewing financial results and for planning purposes. See "Consolidated Reconciliation of GAAP to Non-GAAP Financial Measures" below.
About Xura, Inc.
Xura empowers people to engage with each other, across services, and through devices as part of their digital lifestyle. We help service providers and enterprises deliver and monetize innovative digital experiences through an award-winning portfolio of software solutions, backed by expert services. Our solutions touch more than three billion people through 450 service providers and enterprises in 130+ countries. You can find us at www.Xura.com.
Forward-Looking Statements
This press release includes "forward-looking statements." Forward-looking statements include financial projections, statements of plans and objectives for future operations, statements of future economic performance, and statements of assumptions relating thereto. In some cases, forward-looking statements can be identified by the use of terminology such as "may," "expects," "plans," "anticipates," "estimates," "believes," "potential," "projects," "forecasts," "intends," or the negative thereof or other comparable terminology. By their very nature, forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results, performance and the timing of events to differ materially from those anticipated, expressed or implied by the forward-looking statements in this press release. Such risks or uncertainties may give rise to future claims and increase exposure to contingent liabilities. These risks and uncertainties relate to (among other factors) the market price of our stock, operating expenses and cash flows, variability of our tax provision, and the additional risks described in the sections entitled "Forward-Looking Statements" and Item 1A, "Risk Factors" and elsewhere in the company's Annual Report on Form 10-K, its Quarterly Report on Form 10-Q for the quarter ended July 31, 2015, or in other subsequently filed periodic, current or other reports. We undertake no commitment to update or revise any forward-looking statements except as required by law.
These risks and uncertainties discussed above, as well as others, are discussed in greater detail in our filings with the SEC. The documents and reports we file with the SEC are available through us, or our website, www.Xura.com, or through the SEC's Electronic Data Gathering, Analysis, and Retrieval system (EDGAR) at www.sec.gov.
XURA, INC. AND SUBSIDIARIES | ||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | ||||
(In thousands, except share and per share data) | ||||
Three Months Ended July 31, | Six Months Ended July 31, | |||
2015 | 2014 | 2015 | 2014 | |
Revenue: | ||||
Product revenue | $ 17,005 | $ 20,062 | $ 27,112 | $ 37,072 |
Service revenue | 44,624 | 54,926 | 80,222 | 102,998 |
Total revenue | 61,629 | 74,988 | 107,334 | 140,070 |
Costs and expenses: | ||||
Product costs | 12,715 | 18,808 | 25,668 | 28,703 |
Service costs | 27,249 | 39,148 | 58,053 | 80,138 |
Research and development, net | 8,235 | 9,813 | 16,515 | 18,172 |
Selling, general and administrative | 19,686 | 23,059 | 39,559 | 48,619 |
Other operating expenses: | ||||
Restructuring expenses | 4,238 | 1,171 | 7,646 | 3,043 |
Total other operating expenses | 4,238 | 1,171 | 7,646 | 3,043 |
Total costs and expenses | 72,123 | 91,999 | 147,441 | 178,675 |
Loss from operations | (10,494) | (17,011) | (40,107) | (38,605) |
Interest income | 89 | 100 | 173 | 215 |
Interest expense | (167) | (231) | (360) | (354) |
Foreign currency transaction loss, net | (4,202) | (2,949) | (9,775) | (930) |
Other income (expense), net | 77 | (413) | 179 | (465) |
Loss before income tax benefit (expense) | (14,697) | (20,504) | (49,890) | (40,139) |
Income tax benefit (expense) | 2,534 | (1,877) | (2,253) | (4,337) |
Loss from continuing operations | (12,163) | (22,381) | (52,143) | (44,476) |
Income from discontinued operations | 175,060 | 5,515 | 188,379 | 11,479 |
Net income (loss) | $ 162,897 | $ (16,866) | $ 136,236 | $ (32,997) |
Weighted average common shares outstanding: | ||||
Basic & diluted | 22,005,116 | 22,401,902 | 21,936,379 | 22,348,835 |
Earnings (loss) per share - basic & diluted: | ||||
Continuing operations | $ (0.55) | $ (1.00) | $ (2.38) | $ (1.99) |
Discontinued operations | 7.95 | 0.25 | 8.59 | 0.51 |
$ 7.40 | $ (0.75) | $ 6.21 | $ (1.48) |
XURA, INC. AND SUBSIDIARIES | ||
CONDENSED CONSOLIDATED BALANCE SHEETS | ||
(In thousands, except share and per share data) | ||
July 31, 2015 | January 31, 2015 | |
ASSETS | ||
Current assets: | ||
Cash and cash equivalents | $ 346,074 | $ 158,121 |
Restricted cash and bank deposits | 55,584 | 35,802 |
Accounts receivable, net of allowance of $3,225 and $4,403, respectively | 29,653 | 71,670 |
Inventories | 14,296 | 17,817 |
Deferred cost of revenue | 2,855 | 7,059 |
Deferred income taxes | 14,298 | 13,781 |
Prepaid expenses | 11,288 | 15,156 |
Other current assets | 31,663 | 10,570 |
Total current assets | 505,711 | 329,976 |
Property and equipment, net | 38,496 | 49,230 |
Goodwill | 67,622 | 151,217 |
Intangible assets, net | 1,440 | 4,049 |
Deferred cost of revenue | 19,303 | 30,437 |
Deferred income taxes | 1,731 | 3,064 |
Long-term restricted cash | 5,253 | 7,940 |
Other assets | 16,406 | 30,439 |
Total assets | $ 655,962 | $ 606,352 |
LIABILITIES AND EQUITY | ||
Current liabilities: | ||
Accounts payable and accrued expenses | $ 145,151 | $ 121,720 |
Deferred revenue | 103,574 | 185,323 |
Deferred income taxes | 1,593 | 1,491 |
Income taxes payable | — | 2,166 |
Total current liabilities | 250,318 | 310,700 |
Deferred revenue | 62,313 | 89,999 |
Deferred income taxes | 51,088 | 56,815 |
Other long-term liabilities | 132,350 | 135,456 |
Total liabilities | 496,069 | 592,970 |
Commitments and contingencies | ||
Equity: | ||
Common stock, $0.01 par value - authorized, 100,000,000 shares; issued 22,908,954 and 22,591,411 shares, respectively; outstanding, 21,993,027 and 21,830,081 shares, respectively | 229 | 226 |
Preferred stock, $0.01 par value - authorized, 100,000 shares | — | — |
Treasury stock, at cost, 915,927 and 761,330 shares, respectively | (20,353) | (17,211) |
Accumulated earnings (deficit) | 89,845 | (46,390) |
Additional paid in capital | 52,065 | 45,935 |
Accumulated other comprehensive income | 38,107 | 30,822 |
Total equity | 159,893 | 13,382 |
Total liabilities and equity | $ 655,962 | $ 606,352 |
XURA, INC. AND SUBSIDIARIES | ||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||
(In thousands) | ||
Six Months Ended July 31, | ||
2015 | 2014 | |
Cash flows from operating activities: | ||
Net income (loss) | $ 136,236 | $ (32,997) |
Non-cash operating items: | ||
Depreciation and amortization | 9,364 | 9,561 |
Gain on BSS Business sale | (201,602) | — |
Provision for doubtful accounts | 331 | 331 |
Stock-based compensation expense | 6,133 | 5,923 |
Deferred income taxes | (4,850) | 3,131 |
Inventory write-downs | 1,303 | 1,108 |
Other non-cash items, net | 420 | 446 |
Changes in assets and liabilities: | ||
Accounts receivable | 3,701 | (16,392) |
Inventories | 1,417 | (8,624) |
Deferred cost of revenue | 4,747 | 11,592 |
Prepaid expense and other current assets | (32,838) | (5,580) |
Accounts payable and accrued expense | 25,642 | (16,195) |
Income taxes | (4,223) | (1,053) |
Deferred revenue | (4,954) | (5,750) |
Tax contingencies | 15,352 | 3,598 |
Other assets and liabilities | (5,442) | 1,517 |
Net cash used in operating activities | (49,263) | (49,384) |
Cash flows from investing activities: | ||
Purchases of property and equipment | (7,982) | (11,472) |
Advance payment for acquisition of Solaiemes | — | (2,678) |
Net change in restricted cash and bank deposits | (18,477) | (4,027) |
Proceeds from asset sales | 110 | 46 |
Proceeds from BSS Business sale net of escrow withheld of $26 million | 266,081 | — |
Net cash provided by (used in) investing activities | 239,732 | (18,131) |
Cash flows from financing activities: | ||
Payment for repurchase of common stock in connection with tax liabilities upon settlement of stock awards | (532) | (972) |
Payment for repurchase of common stock under repurchase program | (2,351) | (3,573) |
Proceeds from exercises of stock options | — | 40 |
Net cash used in financing activities | (2,883) | (4,505) |
Effects of exchange rates on cash and cash equivalents | 367 | (973) |
Net increase (decrease) in cash and cash equivalents | 187,953 | (72,993) |
Cash and cash equivalents, beginning of period | 158,121 | 254,580 |
Cash and cash equivalents, end of period | $ 346,074 | $ 181,587 |
Non-cash investing transactions: | ||
Accrued but unpaid purchases of property and equipment | $ 785 | $ 4,587 |
Inventory transfers to property and equipment | $ 824 | $ 1,673 |
XURA, INC. AND SUBSIDIARIES | ||||
CONSOLIDATED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES | ||||
(UNAUDITED) | ||||
Three Months Ended July 31, | Six Months Ended July 31, | |||
2015 | 2014 | 2015 | 2014 | |
(Dollars in thousands) | ||||
Loss from operations | $ (10,494) | $ (17,011) | $ (40,107) | $ (38,605) |
Expense adjustments: | ||||
Stock-based compensation expense | 2,589 | 2,382 | 4,965 | 4,535 |
Amortization of intangible assets | 86 | — | 172 | — |
Compliance-related professional fees | 654 | 335 | 705 | 704 |
Compliance-related compensation and other expenses | 229 | — | 237 | (70) |
Strategic related costs | 1,875 | 1,100 | 3,769 | 2,390 |
Write-off of property and equipment | 78 | 169 | 104 | 178 |
Certain litigation settlements and related costs | 12 | 41 | 54 | 5 |
Restructuring expenses | 4,201 | 1,171 | 7,609 | 3,043 |
Loss (gain) on sale of fixed assets | 154 | (14) | 152 | (19) |
Other | — | 305 | (125) | 600 |
Total expense adjustments | 9,878 | 5,489 | 17,642 | 11,366 |
Xura Performance | (616) | (11,522) | (22,465) | (27,239) |
Depreciation | 3,339 | 3,261 | 6,706 | 6,422 |
Adjusted EBITDA | 2,723 | (8,261) | (15,759) | (20,817) |
Adjusted EBITDA earnings (loss) per share - basic & diluted | $ 0.12 | $ (0.37) | $ (0.72) | $ (0.93) |
CONTACT: Luke Todd - Xura, Inc (781) 213-2131 Luke.Todd@xura.com
1 Year (MM) Chart |
1 Month (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions